Evidence map›Paper›PMID 30863803›Full record

ArticleAnnals of hepato-biliary-pancreatic surgery2019

Partial ALPPS with a longer wait between procedures is safe and yields adequate future liver remnant hypertrophy.

Nagappan Kumar, Trish Duncan, David O'Reilly, Zsolt Káposztás, Craig Parry, John Rees, Sameer Junnarkar

Abstract read
In one paragraph

Article in Annals of hepato-biliary-pancreatic surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nagappan KumarCardiff Liver Unit, University Hospital of Wales, Cardiff, UK.
Trish DuncanCardiff Liver Unit, University Hospital of Wales, Cardiff, UK.
David O'ReillyCardiff Liver Unit, University Hospital of Wales, Cardiff, UK.
Zsolt KáposztásMoritz Kaposi Teaching General Hospital, Kaposvár, Hungary.
Craig ParryDepartment of Radiology, University Hospital of Wales, Cardiff, UK.
John ReesDepartment of Radiology, University Hospital of Wales, Cardiff, UK.
Sameer JunnarkarDepartment of Surgery, Tan Tock Seng Hospital, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUNDS/

aimsAssociating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) has generated controversy due to high morbidity and mortality. We present our series of patients with 30-40% parenchymal transection and minimal hilar dissection.

methodsPatients who had partial ALPPS between April 2015 and April 2016 were included. Patients with colorectal liver metastases (CRLM) had their future liver remnants (FLR) cleared with metastasectomies. The liver was divided along the future line of transection to 30-40%, right portal vein was stapled and divided without extensive hilar dissection, with minimal handling of right liver, which was not mobilised. We preserved the middle hepatic vein. Data were collected prospectively for hypertrophy of the FLR, morbidity and mortality.

resultsAmong the 8 patients (age 25-68) investigated, one patient with cholangiocarcinoma had portal vein embolization prior to partial ALPPS. All patients completed two stages with adequate FLR hypertrophy at a median of 28 days. No mortality was found. The median length of stay after stages 1 and 2 was 9 and 9.6 days, respectively. The median increase in FLR was 38%.

conclusionsA limited transection of 30-40%, minimal hilar dissection and longer wait between stages yielded adequate FLR hypertrophy with low morbidity and no mortality.

Indexed as

ALPPSColorectal liver metastasesFuture liver remnantHypertrophyLiver resection

Identifiers

PMID30863803
PMCPMC6405373

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.